Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Uhel

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 20, 2020
Norepinephrine in Septic Shock: A Mixed BlessingFabrice Uhel, Tom van der Poll
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2009
Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection biasPierre Tattevin, Fabrice Uhel, Fabien Fily
Annals of Translational Medicine|February 12, 2019
Initiation of renal replacement therapy in patients with sepsis: more to it than meets the eyeFabrice Uhel, Hessel Peters-Sengers, Tom van der Poll
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2021
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2Noémie Zucman, Fabrice Uhel, Diane Descamps, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2019
Early-stage myeloid-derived suppressor cell count: Basophil exclusion mattersFabrice Uhel, Imane Azzaoui, Simon Le Gallou, et al.
Journal of Critical Care|January 12, 2025
Water treatment-free prolonged intermittent kidney replacement therapy: A new approach for kidney replacement therapy in the ICU setting. A retrospective studyNoémie Zucman, Fabrice Uhel, Charles Verney, et al.
Stem Cell Reviews and Reports|November 24, 2022
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?Stéphanie Pons, Fabrice Uhel, Eric Frapy, et al.
Shock (Augusta, Ga.)|November 26, 2019
Tenascin C Plasma Levels in Critically Ill Patients with or Without Sepsis: A Multicenter Observational StudyMariska T Meijer, Fabrice Uhel, Olaf L Cremer, et al.
American Journal of Respiratory and Critical Care Medicine|October 7, 2017
Reply to Patel et al.: Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic ShockFabrice Uhel, Christophe Camus, Arnaud Gacouin, et al.
Drug Metabolism and Pharmacokinetics|April 3, 2013
A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphismsFlorian Lemaitre, Mathilde Barbaz, Lucie-Marie Scailteux, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|August 20, 2020
Norepinephrine in Septic Shock: A Mixed BlessingFabrice Uhel, Tom van der Poll
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2009
Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection biasPierre Tattevin, Fabrice Uhel, Fabien Fily
Annals of Translational Medicine|February 12, 2019
Initiation of renal replacement therapy in patients with sepsis: more to it than meets the eyeFabrice Uhel, Hessel Peters-Sengers, Tom van der Poll
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2021
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2Noémie Zucman, Fabrice Uhel, Diane Descamps, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2019
Early-stage myeloid-derived suppressor cell count: Basophil exclusion mattersFabrice Uhel, Imane Azzaoui, Simon Le Gallou, et al.
Journal of Critical Care|January 12, 2025
Water treatment-free prolonged intermittent kidney replacement therapy: A new approach for kidney replacement therapy in the ICU setting. A retrospective studyNoémie Zucman, Fabrice Uhel, Charles Verney, et al.
Stem Cell Reviews and Reports|November 24, 2022
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?Stéphanie Pons, Fabrice Uhel, Eric Frapy, et al.
Shock (Augusta, Ga.)|November 26, 2019
Tenascin C Plasma Levels in Critically Ill Patients with or Without Sepsis: A Multicenter Observational StudyMariska T Meijer, Fabrice Uhel, Olaf L Cremer, et al.
American Journal of Respiratory and Critical Care Medicine|October 7, 2017
Reply to Patel et al.: Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic ShockFabrice Uhel, Christophe Camus, Arnaud Gacouin, et al.
Drug Metabolism and Pharmacokinetics|April 3, 2013
A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphismsFlorian Lemaitre, Mathilde Barbaz, Lucie-Marie Scailteux, et al.
Pageof 8